This research also found reductions in KLRG1 expression in total CD8+T and naïve CD4+T cells of moderate CFS/ME patients, which suggests that these cells may have a reduced ability to inhibit T cell function and activation. The gene discussed is CD4; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.